ANDA 86936, held by Alpharma US Pharmaceuticals. Brompheniramine Maleate.
As of Nov 21, 2026, ANDA 86936 (Brompheniramine Maleate), held by Alpharma US Pharmaceuticals, was first approved by FDA on Jul 16, 1981, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 16, 1981 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Brompheniramine Maleate2MG/5ML · elixir;oral | Brompheniramine Maleate | Discontinued |
| Mar 10, 1987 | Supplement 3Manufacturing | Approved | None posted |
| Mar 10, 1987 | Supplement 4Manufacturing | Approved | None posted |
| Mar 26, 1982 | Supplement 1Manufacturing | Approved | None posted |
| Jul 16, 1981 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters